We are live on
!
Find out more
HP
Hikari Power Portfolio holdings
AUM
$855M
1-Year Est. Return
14.24%
This Fund
S&P 500
This Quarter
Est. Return
+1.74%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$928M
AUM Growth
-$26M
(-2.7%)
Cap. Flow
-$37.9M
Cap. Flow
% of AUM
-4.08%
Top 10 Holdings %
Top 10 Hldgs %
59.54%
Holding
150
New
27
Increased
25
Reduced
20
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$9.14M |
| 2 |
Altria Group
MO
|
+$5.27M |
| 3 |
Johnson & Johnson
JNJ
|
+$3.14M |
| 4 |
Medtronic
MDT
|
+$2.37M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$2.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$16.7M |
| 2 |
RTX Corp
RTX
|
+$12.1M |
| 3 |
General Mills
GIS
|
+$11M |
| 4 |
GE Aerospace
GE
|
+$9.69M |
| 5 |
Wells Fargo
WFC
|
+$4.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.49% |
| 2 | Healthcare | 20.48% |
| 3 | Industrials | 9.59% |
| 4 | Consumer Staples | 5.51% |
| 5 | Materials | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ecolab
ECL
$79.8B
| $415K | 0.04% |
2,100
| – | – |
|
77
Viking Therapeutics
VKTX
$3.94B
| $415K | 0.04% |
50,000
| – | – |
|
|
MRSN
78
DELISTED
Mersana Therapeutics
MRSN
| $365K | 0.04% |
3,610
| – | – |
|
|
CARM
79
DELISTED
Carisma Therapeutics
CARM
| $318K | 0.03% |
10,593
-10
| -0.1% | -$299 |
|
|
DO
80
DELISTED
Diamond Offshore Drilling
DO
| $312K | 0.03% |
35,200
| – | – |
|
|
ERUS
81
DELISTED
iShares MSCI Russia ETF
ERUS
| $309K | 0.03% |
7,850
| – | – |
|
82
Thermo Fisher Scientific
TMO
$224B
| $294K | 0.03% |
+1,000
| New | +$275K |
|
83
Aldeyra Therapeutics
ALDX
$91.1M
| $267K | 0.03% |
44,520
| – | – |
|
|
SPHS
84
DELISTED
Sophiris Bio, Inc.
SPHS
| $254K | 0.03% |
300,900
+100,000
| +50% | +$87.6K |
|
85
Emcor
EME
$36B
| $226K | 0.02% |
+2,570
| New | +$208K |
|
|
FSTX
86
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $226K | 0.02% |
15,334
+1,950
| +15% | +$52.2K |
|
87
H&R Block
HRB
$5.92B
| $222K | 0.02% |
7,590
-2,170
| -22% | -$58.3K |
|
88
ManpowerGroup
MAN
$2.62B
| $222K | 0.02% |
+2,300
| New | +$210K |
|
89
Cencora
COR
$63.7B
| $221K | 0.02% |
+2,590
| New | +$205K |
|
90
Prestige Consumer Healthcare
PBH
$2.54B
| $220K | 0.02% |
+6,960
| New | +$207K |
|
91
Synchrony
SYF
$25.5B
| $218K | 0.02% |
+6,300
| New | +$214K |
|
92
Nektar Therapeutics
NKTR
$2.55B
| $210K | 0.02% |
+393
| New | +$197K |
|
93
Innoviva
INVA
$1.5B
| $209K | 0.02% |
+14,340
| New | +$203K |
|
94
Applied Materials
AMAT
$417B
| $208K | 0.02% |
+4,630
| New | +$195K |
|
95
Advanced Energy
AEIS
$13.1B
| $205K | 0.02% |
+3,650
| New | +$196K |
|
|
MTOR
96
DELISTED
MERITOR, Inc.
MTOR
| $205K | 0.02% |
+8,470
| New | +$190K |
|
97
HP
HPQ
$26.6B
| $204K | 0.02% |
+9,790
| New | +$194K |
|
|
WW
98
DELISTED
WW International
WW
| $202K | 0.02% |
+10,600
| New | +$210K |
|
|
CALA
99
DELISTED
Calithera Biosciences, Inc
CALA
| $195K | 0.02% |
2,500
| – | – |
|
100
Corcept Therapeutics
CORT
$12.1B
| $187K | 0.02% |
+16,790
| New | +$187K |
|
Similar funds
QIM
NOCM
OAM
EPIMS
BCM
PCM
BOTOTLSJU
TSS
Hikari Power's Q2 2019 Portfolio in Review
As of Q2 2019, Hikari Power held 150 positions worth $928M, down 2.7% from $954M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Hikari Power withdrew a net $37.9M in Q2 2019, closing 35 positions and reducing 20 holdings. Its most notable exit was Sanofi, an estimated $3.15M position sold in full.
By sector, the portfolio is most concentrated in Financials at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Hikari Power opened a new position in Vanguard Short-Term Bond ETF worth $9.23M.
- Hikari Power's largest Q2 2019 buy was Vanguard Short-Term Bond ETF: 114,600 shares worth $9.23M.
- Hikari Power added most to Altria Group in Q2 2019, an estimated $5.27M increase.
- Hikari Power's biggest Q2 2019 reduction was IBM, cutting an estimated $16.7M.
- Hikari Power fully exited Sanofi in Q2 2019, selling an estimated $3.15M.
- Hikari Power's ten largest holdings make up 60% of its $928M portfolio in Q2 2019.
- Hikari Power opened 27 new positions and closed 35 in Q2 2019.
- Hikari Power's portfolio value fell 2.7% quarter-over-quarter to $928M.
Based on Hikari Power's 13F filing for Q2 2019, filed 8 Aug 2019.